The thriving area of Monksland received another huge economic boost last weekend when it was announced that 50 jobs would be created through the expansion of a pharmaceuticals plant.
The news was part of a €100 million investment by Alexion Pharmaceuticals in a significant expansion of its Athlone operations. It will mean that more than 100 people will be employed at the site.
The company has lodged a planning application with Roscommon County Council to build a new biologics manufacturing facility at the site, where the new jobs will be based.
The plant would be 6,025 sq. m. (about 64,800 sq. ft.), spead over a three-storey building, while there would also be 70 additional car parking spaces.
“Alexion is delighted to announce this additional expansion to our existing Athlone site as we deliver upon our mission to transform the lives of patients with ultra-rare diseases,” Julie O’Neill, the Executive Vice-President of global operations at Alexion, said.
“Ireland is a key location for Alexion’s global operations and we are committed to further developing our manufacturing facilities in the country to support increasing production needs of our highly innovative and life-transforming therapies.”
The new facility demonstrates Alexion’s continued commitment to Ireland and to Athlone since first announcing a presence in the area in 2013.
The current Athlone site houses a vial fill-finish facility.
“We already have a well-established presence in Athlone since 2013, with a great local workforce, and we are firmly committed to this region going forward,” Gráinne McAleese, the General Manager of Alexion Ireland, said.